Niagen Bioscience, Inc. (NAGE): auditor change — ChromaDex auditor Marcum resigns effective Oct 31 due to conflict from CBIZ merger

Niagen Bioscience, Inc.

Marcum LLP resigned as independent auditor effective Oct 31, 2024, citing independence concerns from its impending merger with CBIZ Inc.
CBIZ provides HR consulting and health insurance brokerage services to ChromaDex, creating a conflict under independence rules.
Marcum's audit reports for fiscal years 2022 and 2023 contained no adverse opinions or qualifications.
No disagreements or reportable events occurred during the relevant periods; Board and Audit Committee were not involved in the resignation decision.
Company has not yet named a replacement auditor; Marcum's letter to SEC filed as Exhibit 16.1.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Marcum LLP resigned as auditor of Niagen Bioscience, Inc..

Action: resignation
Auditor: Marcum LLP

Exact text from the filing

On October 8, 2024, Marcum LLP (“Marcum”) notified ChromaDex Corporation (the “Company”) that it was resigning, effective October 31, 2024, as the independent registered public accounting firm for the Company due to independence concerns relating to Marcum’s impending merger with CBIZ Inc.

View on SEC.gov

Browse all auditor changes →

Niagen Bioscience, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-042724

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.